Global Perspective on Telemedicine for Parkinson's Disease
- PMID: 33579872
- PMCID: PMC8385495
- DOI: 10.3233/JPD-202411
Global Perspective on Telemedicine for Parkinson's Disease
Abstract
Telemedicine programs are particularly suited to evaluating patients with Parkinson's disease (PD) and other movement disorders, primarily because much of the physical exam findings are visual. Telemedicine uses information and communication technologies to overcome geographical barriers and increase access to healthcare service. It is particularly beneficial for rural and underserved communities, groups that traditionally suffer from lack of access to healthcare. There is a growing evidence of the feasibility of telemedicine, cost and time savings, patients' and physicians' satisfaction, and its outcome and impact on patients' morbidity and quality of life. In addition, given the unusual current situation with the COVID-19 pandemic, telemedicine has offered the opportunity to address the ongoing healthcare needs of patients with PD, to reduce in-person clinic visits, and human exposures (among healthcare workers and patients) to a range of infectious diseases including COVID-19. However, there are still several challenges to widespread implementation of telemedicine including the limited performance of parts of the neurological exam, limited technological savvy, fear of loss of a personal connection, or uneasiness about communicating sensitive information. On the other hand, while we are facing the new wave of COVID-19 pandemic, patients and clinicians are gaining increasing experience with telemedicine, facilitating equity of access to specialized multidisciplinary care for PD. This article summarizes and reviews the current state and future directions of telemedicine from a global perspective.
Keywords: Parkinson’s disease; Telemedicine; movement disorders; telehealth.
Conflict of interest statement
Esther Cubo: Spanish government grants (Fondo de Investigación Sanitaria 2020-2023), Travel grants (Allergan, Boston, Abbvie).
Meredith Spindler: Clinical trial funding (Abbvie, US WorldMeds, Sanofi, Abbott, Insightec)
Ali Shalash: no relevant financial disclosures.
Figures
References
-
- Khalid S, Varade P, Bhattacharya P, Madhavan R (2015) International teleneurology. In Teleneurology in Practice, Tsao J, Demaerschalk B, eds. Springer, New York, NY..
-
- https://www.who.int/goe/publications/goe_telemedicine_2010.pdf. Accessed on 24 July 2020.
-
- Burke JF, Albin RL (2011) Do neurologists make a difference in Parkinson disease care? Neurology 77, 814–815. - PubMed
-
- Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR, International Parkinson and Movement Disorder Society Telemedicine Task Force (2014) The past, present, and future of telemedicine for Parkinson’s disease. Mov Disord 29, 871–883. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical